"It's all about buying time," said Kathy Giusti, president of the Multiple Myeloma Research Foundation. (BioWorld Financial Watch)

What a difference a year makes. Or not.At this point in 2002, ICOS Corp. had just received word from the FDA that its erectile dysfunction drug candidate Cialis (taladifil), partnered with Eli Lilly and Co., was approvable if three issues were cleared up. (See BioWorld Financial Watch, May 6, 2002.)